2017•Neuromuscular DisordersRequires access

Myostatin expression levels in neuromuscular diseases participates in anti-myostatin clinical failure

Virginie Mariot, Romain Joubert, Christophe Hourdé, Léonard Feasson, Michael G. Hanna, F. Muntoni, Thierry Maisonobe, Laurent Servais, Rozen Le Panse, O. Benveniste, T. Stojkovic, Pedro Machado, Thomas Voit, A. Buj-Bello, Julie Dumonceaux

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Myostatin, Wasting, Medicine, Biology, Internal medicine, Endocrinology, Skeletal muscle

Related papers

Back to paper searchBrowse research topicsOriginal source
Myostatin expression levels in neuromuscular diseases participates in anti-myostatin clinical failure — Research Paper | ScholarLens